As explained by MPEP 2111.04, the phrase "adapted to" is sometimes interpreted as the narrower "configured to" and other times as the broader "capable of." The MPEP directs "[t]he determination of whether each of these clauses is a limitation in a claim depends on the specific facts of the case," and cites In re Giannelli to show that the court determined the scope of "adapted to" by analyzing the written description. ...more »
The current text of MPEP 2111.05, if read quickly, seems to suggest that a "function" of "descriptive material" itself carries patentable weight. But this interpretation is not correct: A sheet of instructions as part of the kit claim in In re Ngai (cited in this section) was found to *not* have patentable weight. The "functional" nature of the particular instructions did not save the claims from anticipation over a ...more »
Preparing EPS submission, i notice most of the forms are expired, that is, beyond their 'use by' dates. Where are up-to-date forms located?
It appears, in my experience, that there is confusion regarding this section of the MPEP and it would be very helpful to examiners if the MPEP would provide a more extensive discussion of preambles, intended uses and when statements in preambles actually limit the claimed Invention. Quite respectfully, the statement in the MPEP, upon citing In re Schriber, indicates 'If a prior art structure is capable of performing ...more »
As a suggestion, in relation to Minton v. Nat’l Ass’n of Securities Dealers, Inc, this section could be expanded, if deemed applicable, to include other words with a similar meaning to 'wherein' and 'whereby' which may also be interpreted as merely indicating the intended outcome of a positively-recited method step; e.g., 'thereby,' thereto,' 'therein.' It would also be very helpful, especially for new examiners, to ...more »
The MPEP here states: When a compound or composition claim is limited by a particular use, enablement of that claim should be evaluated based on that limitation. See In re Vaeck, 947 F.2d 488, 495, 20 USPQ2d 1438, 1444 (Fed. Cir. 1991) (claiming a chimeric gene capable of being expressed in any cyanobacterium and thus defining the claimed gene by its use). Quite respectfully, is it 'defining the claimed gene by ...more »
The patent list page on Private PAIR can not show most updated date of document from USPTO for a particulary application, and misslead user think there is not new document or notice from USPTO. Even worse I just received same notice letter which has gone thru over two month to reach me and overdue. To improve the system, it is ideally to set the system automatically send an email to remind the account holder to check ...more »
The zip file containing the March 2014 version of the 9th edition of the MPEP still uses the name of the previous version, ie. e9r-11-2013.zip.
It would be less confusing if the name was consistent with the current version.
There is one place in the MPEP that uses the term "non-analogous" -- MPEP 1504.03.
Every other place in the MPEP uses "nonanalogous."
In the interest of consistency...perhaps the usage in MPEP 1504.03 should be updated.
Quotation from §172 says "...by section 119(e)hall not apply to designs."
The item below refers to claim markings in a reissue application. MPEP 1451 includes a typo in the section reading "Indicia that a continuation reissue application is being filed are . . .".
In bullet 3, strike "1.175" and replace with 1.173:
3. Amendments in proper format per 37 CFR --1.173--
The time for reply in written restriction practice is now 2 months. As per December 2012 patent law treaty, http://www.uspto.gov/patent/initiatives/patent-law-treaty
Thanks to LIE, Adam Queler and Kevin Bechtel for giving me this information.